Inventor · disambiguated record
Om Dhingra
Also filed as: DHINGRA OM · DHINGRA OM P · DHINGRA OM PARKASH
11 granted patents·5 pending applications·109 citations·filing 1985–2023
89Inventor score
Files withMARIUS PHARMACEUTICALS LLC6MARIUS PHARMACEUTICALS INC3MONSANTO CO3SOV THERAPEUTICS2DIFFERENTIAL DRUG DEV ASSOCIATES LLC1
Top patents by PatentIndex Score
16 records- 0190US11590146B2Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterolsMARIUS PHARMACEUTICALS LLC·Filed 2019·Granted Feb 28, 2023·3 cites·8 claims
- 0290US4747871A2,6-bis(trifluoromethyl)-3-hydroxycarbonyl pyridine, salts and gametocidesMONSANTO CO·Filed 1987·Granted May 31, 1988·44 cites·8 claims
- 0389US11617758B2Emulsion formulationsMARIUS PHARMACEUTICALS LLC·Filed 2020·Granted Apr 4, 2023·3 cites·9 claims
- 0487US10576090B2Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterolsMARIUS PHARMACEUTICALS LLC·Filed 2018·Granted Mar 3, 2020·5 cites·15 claims
- 0586US4735649AGametocidesMONSANTO CO·Filed 1985·Granted Apr 5, 1988·36 cites·4 claims
- 0683US10576089B2Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterolsMARIUS PHARMACEUTICALS LLC·Filed 2013·Granted Mar 3, 2020·5 cites·14 claims
- 0781US12295961B2Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterolsMARIUS PHARMACEUTICALS INC·Filed 2023·Granted May 13, 2025·0 cites·8 claims
- 0875US12357643B2Emulsion formulationsMARIUS PHARMACEUTICALS INC·Filed 2023·Granted Jul 15, 2025·0 cites·6 claims
- 0968US7008599B1High throughput crystal form screening workstation and method of useSMITHKLINE BEECHAM CORP·Filed 2000·Granted Mar 7, 2006·12 cites·18 claims
- 1059US2023398128A1Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatmentMARIUS PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1157US2018021349A1Emulsion formulationsMARIUS PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 1253US2011160168A1Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterolsDIFFERENTIAL DRUG DEV ASSOCIATES LLC·Filed 2010·Application pending·0 cites
- 1346US12403146B2Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatmentMARIUS PHARMACEUTICALS INC·Filed 2020·Granted Sep 2, 2025·0 cites·21 claims
- 1443US2013303495A1Emulsion formulationsSOV THERAPEUTICS·Filed 2013·Application pending·0 cites
- 1536US4634788AHerbicidal glyphosate oxime derivativesMONSANTO CO·Filed 1985·Granted Jan 6, 1987·1 cites·9 claims
- 1636US2011263552A1Modulation of side effect profile of 5-alpha reductase inhibitor therapySOV THERAPEUTICS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Om Dhingra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →